Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Lara Iglesias-Docampo
33  Ergebnisse:
Personensuche X
?
1

Topical heparin as an effective and safe treatment for pati..:

Rodríguez-Garzotto, Analia ; Iglesias-Docampo, Lara ; Díaz-García, C. Vanesa...
Therapeutic Advances in Medical Oncology.  14 (2022)  - p. 175883592210869 , 2022
Link: https://doi.org/10.1177/..
 
?
2

Topical heparin as an effective and safe treatment for pati..:

Analia Rodríguez-Garzotto ; Lara Iglesias-Docampo ; C. Vanesa Díaz-García...
https://doi.org/10.1177/17588359221086911.  , 2022
Link: https://doi.org/10.1177/..
 
?
3

Observational study to analyse the opioid titration process..:

Lara Iglesias-Docampo ; Paola Pimentel-Cáceres ; Mª Paola García-Coves...
https://doi.org/10.17352/ojpm.000010.  , 2019
Link: https://doi.org/10.17352..
 
?
4

Indicators to evaluate quality of care in head and neck can..:

Hernández, Juan Jesús Cruz ; Arrula, Virginia Arrazubi ; Álvarez, Yolanda Escobar...
Clinical and Translational Oncology.  26 (2023)  5 - p. 1089-1097 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Current approach and novel perspectives in nasopharyngeal c..:

Yarza, Ramon ; Bover, Mateo ; Agulló-Ortuño, Maria Teresa.
Journal of Experimental & Clinical Cancer Research.  40 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
6

Four-Year Lasting Sustained Complete Response After Nivolum..:

Bover, Mateo ; Yarza, Ramón ; Docampo, Lara Iglesias
Clinical Lung Cancer.  21 (2020)  1 - p. e1-e5 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Nivolumab vs investigator's choice in recurrent or metastat..:

Ferris, Robert L. ; Blumenschein Jr., George ; Fayette, Jerome...
Oral Oncology.  81 (2018)  - p. 45-51 , 2018
Link: https://doi.org/10.1016/..
 
?
8

TTCC-2019-02: real-world evidence of first-line cetuximab p..:

Rubió-Casadevall, Jordi ; Cirauqui Cirauqui, Beatriz ; Martinez Trufero, Javier...
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
9

Randomized phase 3 noninferiority trial of radiotherapy and..:

Hitt, Ricardo ; Mesía, Ricard ; Lozano, Alicia...
Oral Oncology.  134 (2022)  - p. 106087 , 2022
Link: https://doi.org/10.1016/..
 
?
10

Current approach and novel perspectives in nasopharyngeal c..:

Ramon Yarza ; Mateo Bover ; Maria Teresa Agulló-Ortuño.
https://doi.org/10.1186/s13046-021-02010-9.  , 2021
Link: https://doi.org/10.1186/..
 
?
11

Exploratory analysis of front-line therapies in REVEL: a ra..:

Garon, Edward B. ; Scagliotti, Giorgio Vittorio ; Gautschi, Oliver...
ESMO Open.  5 (2020)  1 - p. e000567 , 2020
Link: https://doi.org/10.1136/..
 
?
12

DataSheet_1_TTCC-2019-02: real-world evidence of first-line..:

Jordi Rubió-Casadevall ; Beatriz Cirauqui Cirauqui ; Javier Martinez Trufero...
doi:10.3389/fonc.2023.1226939.s001.  , 2023
Link: https://doi.org/10.3389/..
 
?
13

TTCC-2019-02: real-world evidence of first-line cetuximab p..:

Jordi Rubió-Casadevall ; Beatriz Cirauqui Cirauqui ; Javier Martinez Trufero...
https://www.frontiersin.org/articles/10.3389/fonc.2023.1226939/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
14

Long-term Outcomes with Nivolumab as First-line Treatment i..:

Gillison, Maura L ; Blumenschein Jr, George ; Fayette, Jerome...
The Oncologist.  27 (2022)  2 - p. e194-e198 , 2022
Link: https://doi.org/10.1093/..
 
?
15

Topical heparin as an effective and safe treatment for pati..:

Rodríguez-Garzotto, Analia ; Iglesias-Docampo, Lara ; Díaz-García, C. Vanesa...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958526/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15